title: Effects of intravenous glucagon-like peptide-1 on glucose control and hemodynamics after coronary artery bypass surgery in patients with type 2 diabetes.
authors: Karsten
authors: K
authors: Müssig
authors: Arzu
authors: A
authors: Oncü
authors: Philipp
authors: P
authors: Lindauer
authors: Alexandra
authors: A
authors: Heininger
authors: Hermann
authors: H
authors: Aebert
authors: Klaus
authors: K
authors: Unertl
authors: Gerhard
authors: G
authors: Ziemer
authors: Hans-Ulrich
authors: HU
authors: Häring
authors: Jens J
authors: JJ
authors: Holst
authors: Baptist
authors: B
authors: Gallwitz
mesh_terms: D000368:Aged; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism; D003327:Coronary Disease / Q000150:complications / Q000503:physiopathology* / Q000601:surgery; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage*; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D054795:Incretins / Q000008:administration & dosage*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D054795:Incretins; D052216:Glucagon-Like Peptide 1